Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Germany
/
Healthcare
/
Carl Zeiss Meditec
AFX
Carl Zeiss Meditec
Regulatory Uncertainty And Trade Tensions Will Depress Margins
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 15 Analysts
Published
28 Jun 25
Updated
09 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
€38.63
8.5% overvalued
intrinsic discount
09 Aug
€41.92
Loading
1Y
-30.5%
7D
-9.4%
Author's Valuation
€38.6
8.5% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
€38.6
8.5% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
3b
2014
2017
2020
2023
2025
2026
2028
Revenue €2.5b
Earnings €237.9m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
6.36%
Medical Equipment revenue growth rate
0.31%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
5.67%
Calculation
€237.86m
Earnings '28
x
15.71x
PE Ratio '28
=
€3.74b
Market Cap '28
€3.74b
Market Cap '28
/
82.50m
No. shares '28
=
€45.30
Share Price '28
€45.30
Share Price '28
Discounted to 2025 @ 5.67% p.a.
=
€38.39
Fair Value '25